Our solutions

Advanced AI tools for improved disease prediction and monitoring

View all solutions

Best-in-class brain segmentation and volumetric analysis

Accurately visualize lesions and lesion volume change

Monitoring and longitudinal tracking of ARIA-E and ARIA-H

Automated CT alignment for fast, accurate diagnosis

Automated tracer activity quantification

Pre- and post-operative 3D volume analysis of brain tumors
About

We merge state-of-the-art medical imaging with the power of clinical data and machine learning to empower physicians in making more accurate and timely diagnostic decisions.

Find out more

Careers
Join the team leading the way in radiology AI applications

Events
Meet the Cortechs.ai team in a city near you

Partnerships
The partnerships and strategic alliances behind Cortechs.ai

Team
The experts behind our industry-leading software and services
Support

Technical and account information for existing Cortechs.ai customers

Find out more

Submit a ticket
Log an issue or query with our service team

Resource library
View our webinars, user guides and technical specs
Insights

Discover the latest AI image quantification news in your role or specialism.

Find out more

Case studies
See how Cortechs.ai solutions are elevating patient care

Cortechs.ai news
The latest headlines from Cortechs.ai

Industry news
What you need to know about AI radiology

Product updates
Discover what's new in our AI radiology solutions

Published research
Evidence-based validation of our impact on neuroimaging

Whitepapers
Learn more about Whitepapers
Cloud Login
Contact

Volumetric MRI markers and predictors of disease activity in early multiple sclerosis: a longitudinal cohort study

By Cortechs.ai
Nov 18 2023

2 mins

This study compares clinical and MRI parameters between patients with clinically isolated syndrome and those converting to clinically definite multiple sclerosis within 2 years, to identify volumetric MRI predictors of this conversion and to assess effect of early relapses. 2012.

Share

Insights

2 mins

Apr 26 2024

Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Read more about Cortechs.ai Announces Major FDA 510(k)-Pending Update to NeuroQuant Software

Cortechs.ai news

3 mins

Apr 3 2024

Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Read more about Cortechs.ai Appoints Kyle Frye as New Chief Executive Officer

Cortechs.ai news

2 mins

Nov 21 2023

Our Normative Database

Whitepaper: How Cortechs.ai's normative database was created to accurately compare an individual’s brain structure volume to a healthy population.

View our insights